专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

JPS5730163A Radio cassette with separative function 失效
标题翻译：具有分离功能的无线电卡
公开(公告)号：JPS5730163A
公开(公告)日：1982-02-18
申请号：JP10472280
申请日：1980-07-29
申请人： Shoji Fukumoto
发明人： FUKUMOTO SHIYOUJI
IPC分类号： G11B31/00
CPC分类号： G11B31/003
摘要： PURPOSE:To carry a component having only necessry function upon occasion such as by detaching a cassette recorder part from a main body when recording and reproduction are required by the cassette recorder or by detaching a radio part when listening to the radio is required. CONSTITUTION:A radio cassette recorder consists of two components-- a cassette recorder part (a), which is detachable and independently usable, having a speaker part 1, a power source part and other mechanisms, and a radio part (b), which is detachable and independently usable, having a speaker part 1, a power source part and other mechanisms. A detached component gets along with a battery. The main body has a power plug 2, a signal plug 3, a cover for retaining the radio and cassette recorder parts, and grooves and depressions 6 for facilitating the extraction of a cassette tape 5.
摘要翻译：目的：为了携带具有必要功能的部件，例如当盒式录音机需要记录和再现时，或者当需要收听收音机时，通过拆卸无线电部件，例如在盒式录像机部件从主体分离时。构成：一种无线电盒式录像机由两部分构成：盒式录像机部分（a），其可拆卸且可独立使用，具有扬声器部分1，电源部分和其它机构，以及无线电部分（b），其中具有扬声器部分1，电源部分和其它机构可拆卸且可独立使用。一个分离的组件与电池一起。主体具有电源插头2，信号插头3，用于保持无线电和盒式磁带记录器部件的盖子以及用于便于提取盒式磁带5的凹槽和凹槽6。

2. 发明专利

JPS5725986A Seal with cap that contains cinnabar seal ink 失效
标题翻译：密封包含CINNABAR密封墨水
公开(公告)号：JPS5725986A
公开(公告)日：1982-02-10
申请号：JP10092680
申请日：1980-07-22
申请人： Shoji Fukumoto
发明人： FUKUMOTO SHIYOUJI
IPC分类号： B41K1/36 , B41K1/38
摘要： PURPOSE: To provide the titled seal that is easy to carry and by which sealing is ready only when its cap is removed, wherein a groove is arranged to which a click of the cap can be fitted, and a spongy members are arranged to the cap for applying cinnabar seal ink to the seal.
CONSTITUTION: The groove 5 is arranged adjacent to the tip of the seal 6 for anchoring the click 3 of the cap, and in the cap are arranged the spongy members 2 impregnated with cinnabar seal ink. The cap is attached with a lid 1 for preventing the cinnabar seal ink adjacent thereto from being contaminated and for facilitating the use of said ink when only the ink is required. Every time when the cap is attached to the seal, the seal is applied with the ink.
COPYRIGHT: (C)1982,JPO&Japio
摘要翻译：目的：提供容易携带的标签密封件，只有当盖子被移除时，才能进行密封准备，其中布置有可以安装盖帽的点击的凹槽，并且海绵构件布置在盖子上将朱砂密封油墨施加到密封件上。构成：槽5布置成邻近密封件6的顶端，用于锚固盖的点击3，并且在帽中设置浸渍有朱砂密封油墨的海绵构件2。盖子附有盖1，用于防止与其相邻的朱砂密封墨水被污染，并且仅在需要墨水时便于使用所述墨水。每当盖子连接到密封件上时，密封件都会涂上墨水。

3. 发明专利

JPS5769275A Liquid crystal dial plate of dial-type watch 失效
标题翻译： DIAL型手表的液晶水晶板
公开(公告)号：JPS5769275A
公开(公告)日：1982-04-27
申请号：JP14670180
申请日：1980-10-20
申请人： Shoji Fukumoto
发明人： FUKUMOTO SHIYOUJI
IPC分类号： G04C3/00 , G04G9/00
CPC分类号： G04G9/00
摘要： PURPOSE:To retain a beauty comparable the conventional needle indication type watch when the digital indication fails by providing a digital indication function on the dial plate of a dial-type watch employing a liquid crystal for the dial plate. CONSTITUTION:A liquid crystal is employed for the dial plate of a dial-type watch so as to allow the plate to provide indication 1 for alarming time, calender and the like as desired.
摘要翻译：目的：为了保持与传统的指针式手表相当的美观，当数字指示失败时，通过在表盘上使用液晶的表盘式手表的表盘上提供数字指示功能。构成：对于表盘式手表的表盘采用液晶，以便根据需要允许印版提供警示时间，压光机等的指示1。

4. 发明授权

US5420363A Optically active phenol derivatives and preparation thereof 失效
标题翻译：光学活性酚衍生物及其制备方法
公开(公告)号：US5420363A
公开(公告)日：1995-05-30
申请号：US266494
申请日：1994-06-27
申请人： Mitsuru Shiraishi , Shoji Fukumoto
发明人： Mitsuru Shiraishi , Shoji Fukumoto
IPC分类号： C07C39/15 , C07C59/56 , C07C59/74 , C07C59/88 , C07C69/007 , C07C69/732 , C07C69/734 , C07C69/738 , C07C39/12 , C07C37/11 , C07C39/14
CPC分类号： C07C59/88 , C07C39/15 , C07C59/56 , C07C59/74 , C07C69/007 , C07C69/732 , C07C69/734 , C07C69/738 , C07B2200/07
摘要： An optically active tri-substituted methane compound having, as substituents, an aromatic ring group and a phenyl group having hydroxyl group at ortho or para position can be obtained by allowing a phenol compound unsubstituted at the ortho- or/and para-position to react with an optically active secondary carbinol compound having an aromatic ring group at the alpha-position in the presence of tri-substituted phosphine and diazodicarboxylate or diazodicarboxamide. These and other optically active tri-substituted methane compounds are useful as active ingredients for medicines or as intermediate compounds for preparing medicines.
摘要翻译：通过使在邻位或/或对位未取代的酚化合物反应，可以得到在邻位或对位具有芳环基和具有羟基的苯基作为取代基的光学活性三取代甲烷化合物在三取代的膦和重氮二羧酸酯或重氮二甲酰胺的存在下，在α-位上具有芳环基的光学活性的仲甲醇化合物。这些和其它光学活性三取代的甲烷化合物可用作药物的活性成分或用作制备药物的中间体化合物。

5. 发明授权

US5354913A Optically active phenol derivatives and preparation thereof 失效
标题翻译：光学活性酚衍生物及其制备方法
公开(公告)号：US5354913A
公开(公告)日：1994-10-11
申请号：US85166
申请日：1993-07-02
申请人： Mitsuru Shiraishi , Shoji Fukumoto
发明人： Mitsuru Shiraishi , Shoji Fukumoto
IPC分类号： C07C39/15 , C07C59/56 , C07C59/74 , C07C59/88 , C07C69/007 , C07C69/732 , C07C69/734 , C07C69/738 , C07C39/10 , C07C39/08
CPC分类号： C07C59/88 , C07C39/15 , C07C59/56 , C07C59/74 , C07C69/007 , C07C69/732 , C07C69/734 , C07C69/738 , C07B2200/07
摘要： An optically active tri-substituted methane compound having, as substituents, an aromatic ring group and a phenyl group having hydroxyl group at ortho or para position can be obtained by allowing a phenol compound unsubstituted at the ortho- or/and para-position to react with an optically active secondary carbinol compound having an aromatic ring group at the alpha-position in the presence of tri-substituted phosphine and diazodicarboxylate or diazodicarboxamide. These and other optically active tri-substituted methane compounds are useful as active ingredients for medicines or as intermediate compounds for preparing medicines.
摘要翻译：通过使在邻位或/或对位未取代的酚化合物反应，可以得到在邻位或对位具有芳环基和具有羟基的苯基作为取代基的光学活性三取代甲烷化合物在三取代的膦和重氮二羧酸酯或重氮二甲酰胺的存在下，在α-位上具有芳环基的光学活性的仲甲醇化合物。这些和其它光学活性三取代的甲烷化合物可用作药物的活性成分或用作制备药物的中间体化合物。

6. 发明申请

US20140024650A1 SULFONAMIDE DERIVATIVE AND USE THEREOF 有权
标题翻译：磺酰胺衍生物及其用途
公开(公告)号：US20140024650A1
公开(公告)日：2014-01-23
申请号：US14009456
申请日：2012-04-05
申请人： Shoji Fukumoto , Osamu Ujikawa , Shinji Morimoto , Yasutomi Asano , Satoshi Mikami , Norihito Tokunaga , Masakuni Kori , Toshihiro Imaeda , Koichiro Fukuda , Shinji Nakamura , Kouichi Iwanaga
发明人： Shoji Fukumoto , Osamu Ujikawa , Shinji Morimoto , Yasutomi Asano , Satoshi Mikami , Norihito Tokunaga , Masakuni Kori , Toshihiro Imaeda , Koichiro Fukuda , Shinji Nakamura , Kouichi Iwanaga
IPC分类号： C07C311/07 , C07D401/12 , C07D309/14 , C07D295/092 , C07D333/16 , C07D231/12 , C07D233/56 , C07D211/58 , C07D307/22
CPC分类号： C07C311/07 , C07C311/09 , C07C311/14 , C07C317/28 , C07C323/26 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2603/74 , C07D207/27 , C07D207/273 , C07D209/04 , C07D211/56 , C07D211/58 , C07D211/76 , C07D213/61 , C07D213/64 , C07D213/85 , C07D231/12 , C07D231/14 , C07D233/56 , C07D233/68 , C07D237/04 , C07D239/28 , C07D261/08 , C07D263/32 , C07D277/24 , C07D277/32 , C07D277/62 , C07D295/092 , C07D295/192 , C07D305/06 , C07D307/22 , C07D309/06 , C07D309/14 , C07D333/16 , C07D401/04 , C07D401/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D417/12 , C07D493/08
摘要： Provided is a compound having an AMPA receptor function enhancing action, and useful as a prophylactic or therapeutic drug for depression, Alzheimer's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD) and the like. A compound represented by the formula (I): wherein each symbol is as defined in the present specification, or a salt thereof.
摘要翻译：提供具有AMPA受体功能增强作用的化合物，可用作抑郁症，阿尔茨海默氏病，精神分裂症，注意力缺陷多动障碍（ADHD）等的预防或治疗药物。由式（I）表示的化合物或其盐，其中每个符号如本说明书中所定义。

7. 发明申请

US20100094000A1 PYRAZOLE COMPOUNDS 审中-公开
标题翻译：吡咯化合物
公开(公告)号：US20100094000A1
公开(公告)日：2010-04-15
申请号：US12552701
申请日：2009-09-02
申请人： Shoji FUKUMOTO , Norio OHYABU , Taiichi OHRA , Takahiro SUGIMOTO , Tomoaki HASUI , Koji FUJI , Christopher S. SIEDEM , Cassandra GAUTHIER
发明人： Shoji FUKUMOTO , Norio OHYABU , Taiichi OHRA , Takahiro SUGIMOTO , Tomoaki HASUI , Koji FUJI , Christopher S. SIEDEM , Cassandra GAUTHIER
IPC分类号： C07D417/10
CPC分类号： C07D413/10 , C07D413/14 , C07D417/14
摘要： The present invention relates to wherein each symbol is as defined in the specification. The compound has a superior mineralocorticoid receptor antagonistic action and is useful as an agent for the prophylaxis or treatment of a disease or condition mediated by the mineralocorticoid receptor activation.
摘要翻译：本发明涉及其中每个符号如说明书中所定义的。该化合物具有优异的盐皮质激素受体拮抗作用，并且可用作预防或治疗由盐皮质激素受体激活介导的疾病或病症的药剂。

8. 发明申请

US20090253687A1 Fused Heterocyclic Compounds and Their Use as Mineralocorticoid Receptor Ligands 审中-公开
标题翻译：融合的杂环化合物及其作为盐皮质激素受体配体的用途
公开(公告)号：US20090253687A1
公开(公告)日：2009-10-08
申请号：US12087148
申请日：2006-12-27
申请人： Shoji Fukumoto , Nobuyuki Matsunaga , Taiichi Ohra , Norio Ohyabu , Tomoaki Hasui , Takashi Motoyaji , Christopher Stephen Siedem , Tony Pisal Tang , Lisa A. Demeese , Cassandra Gauthier
发明人： Shoji Fukumoto , Nobuyuki Matsunaga , Taiichi Ohra , Norio Ohyabu , Tomoaki Hasui , Takashi Motoyaji , Christopher Stephen Siedem , Tony Pisal Tang , Lisa A. Demeese , Cassandra Gauthier
IPC分类号： A61K31/542 , C07D285/16 , C07D265/36 , A61K31/538 , C07D279/16 , A61K31/5415 , C07D513/02 , A61P9/00
CPC分类号： C07D417/04 , C07D403/04 , C07D413/04 , C07D413/14 , C07D417/14 , C07D471/04 , C07D495/04 , C07D513/04
摘要： The present invention relates to wherein each symbol is as defined in the specification. The compound has a superior mineral corticoidreceptorantagonistic action and is useful as an agent for the prophylaxis or treatment of hypertension, cardiac failure and the like, a compound having a fused heterocycle, or a prodrug thereof, or a salt thereof; and an agent for the prophylaxis or treatment of hypertension, cardiac failure and the like.
摘要翻译：本发明涉及其中每个符号如说明书中所定义的。该化合物具有优异的矿物质皮质激素受体拮抗作用，可用作预防或治疗高血压，心力衰竭等的药剂，具有稠合杂环的化合物或其前药或其盐; 以及预防或治疗高血压，心力衰竭等的药剂。

9. 发明授权

US06350749B1 Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof 失效
标题翻译：氨基胍腙衍生物，其制备方法及其药物
公开(公告)号：US06350749B1
公开(公告)日：2002-02-26
申请号：US09601866
申请日：2000-08-08
申请人： Mitsuru Shiraishi , Shoji Fukumoto , Keiji Kusumoto
发明人： Mitsuru Shiraishi , Shoji Fukumoto , Keiji Kusumoto
IPC分类号： C07D20908
CPC分类号： C07D221/04 , C07D209/06 , C07D209/88 , C07D215/38 , C07D215/60 , C07D231/56 , C07D237/28 , C07D239/74 , C07D261/20 , C07D307/79 , C07D307/84 , C07D401/04 , C07D405/04 , C07D409/04 , C07D417/04
摘要： The present invention is to provide a compound of the formula: wherein the ring A is an optionally substituted 5- to 6-membered aromatic heterocyclic ring, the ring B an optionally substituted 5- to 6-membered aromatic homocyclic ring or an optionally substituted 5- to 6-membered aromatic heterocyclic ring, R1 is a hydrogen atom, a hydroxy group or a lower alkyl group, and n is 0 or 1, or a salt thereof, which is effective for the prevention or treatment of ischemic cardiac disease, etc., and which is useful as an agent for preventing or treating ischemic cardiac disease, etc. such as myocardial infarction, arrhythmia, etc.
摘要翻译：本发明提供下式的化合物：其中环A为任选取代的5至6元芳族杂环，环B为任选取代的5至6元芳族碳环或任选取代的5 至6元芳族杂环，R 1为氢原子，羟基或低级烷基，n为0或1，或其盐对预防或治疗缺血性心脏病有效等。可用作预防或治疗心肌梗死，心律失常等缺血性心脏病等的药剂。

10. 发明授权

US09527807B2 Sulfonamide derivative and use thereof 有权
标题翻译：磺酰胺衍生物及其用途
公开(公告)号：US09527807B2
公开(公告)日：2016-12-27
申请号：US14009456
申请日：2012-04-05
申请人： Shoji Fukumoto , Osamu Ujikawa , Shinji Morimoto , Yasutomi Asano , Satoshi Mikami , Norihito Tokunaga , Masakuni Kori , Toshihiro Imaeda , Koichiro Fukuda , Shinji Nakamura , Kouichi Iwanaga
发明人： Shoji Fukumoto , Osamu Ujikawa , Shinji Morimoto , Yasutomi Asano , Satoshi Mikami , Norihito Tokunaga , Masakuni Kori , Toshihiro Imaeda , Koichiro Fukuda , Shinji Nakamura , Kouichi Iwanaga
IPC分类号： C07C311/07 , C07D401/12 , C07D309/14 , C07D295/092 , C07D333/16 , C07D231/12 , C07D211/58 , C07C311/09 , C07C311/14 , C07C317/28 , C07C323/26 , C07D209/04 , C07D213/64 , C07D231/14 , C07D233/68 , C07D261/08 , C07D263/32 , C07D277/24 , C07D277/62 , C07D307/22 , C07D405/12 , C07D413/12 , C07D417/12 , C07D405/14 , C07D309/06 , C07D213/85 , C07D401/04 , C07D237/04 , C07D239/28 , C07D409/12 , C07D493/08 , C07D207/27 , C07D207/273 , C07D277/32 , C07D211/56 , C07D211/76 , C07D295/192 , C07D213/61 , C07D305/06 , C07D233/56
CPC分类号： C07C311/07 , C07C311/09 , C07C311/14 , C07C317/28 , C07C323/26 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2603/74 , C07D207/27 , C07D207/273 , C07D209/04 , C07D211/56 , C07D211/58 , C07D211/76 , C07D213/61 , C07D213/64 , C07D213/85 , C07D231/12 , C07D231/14 , C07D233/56 , C07D233/68 , C07D237/04 , C07D239/28 , C07D261/08 , C07D263/32 , C07D277/24 , C07D277/32 , C07D277/62 , C07D295/092 , C07D295/192 , C07D305/06 , C07D307/22 , C07D309/06 , C07D309/14 , C07D333/16 , C07D401/04 , C07D401/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D417/12 , C07D493/08
摘要： Provided is a compound having an AMPA receptor function enhancing action, and useful as a prophylactic or therapeutic drug for depression, Alzheimer's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD) and the like. A compound represented by the formula (I): wherein each symbol is as defined in the present specification, or a salt thereof.
摘要翻译：提供具有AMPA受体功能增强作用的化合物，可用作抑郁症，阿尔茨海默氏病，精神分裂症，注意力缺陷多动障碍（ADHD）等的预防或治疗药物。由式（I）表示的化合物或其盐，其中每个符号如本说明书中所定义。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式